September 21, 2022 — Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the treatment of non-left main bifurcation lesions utilizing the provisional bifurcation stenting technique (using a single stent to treat the bifurcation) with theÂ
September 21, 2022 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, has initiated the first-ever prospective coronary intervention study consisting ofÂ
September 22, 2022 — Medical imaging specialist Avicenna.AI announced a groundbreaking partnership with the MedTech company deepc, offering one of the leadingÂ
September 22, 2022 — Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella-supported patients treated at 109 hospitals in Japan shows a 30-day survival rate of 77% for patients with cardiogenic shock due to myocarditis.
September 22, 2022 — The recipient of the TCT 2022 Thomas J. Linnemeier “Spirit of Interventional Cardiology” Young Investigator Award is Jennifer Rymer, MD, MBA, MHS, John Bush Simpson Assistant Professor of Medicine at the Duke University Medical Center, Durham, NC. The award was announced Sept.
September 20, 2022 — Orchestra BioMed, Inc., a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies, announced the presentation of positive long-term clinical results from the MODERATO II Control Patients Crossover Extension Study ofÂ
September 20, 2022 — Medtronic, a global leader in healthcare technology, today announced the LINQ II Insertable Cardiac Monitor (ICM) system is the first-and-only ICM to receive 510(k) clearance by the U.S.
